Addario Lung Cancer Medical Institute (EIN 261721868) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2008

Legal Domicile

Principal Officer

Ken Krantz

Phone

6505982857

Tax Period

2024-01-01 to 2024-12-31

Addario Lung Cancer Medical Institute, founded in 2008, is a community nonprofit in the Medical Research sector that reported $1.9M in total revenue in fiscal year 2024. Revenue surged 23% from the prior year, signaling strong growth momentum. The organization ran a surplus of $329K, a strong 17% operating margin.

Mission

The Addario Lung Cancer Medical Institute ALCMI is dedicated to catalyzing and accelerating the discovery, development and delivery of new and more effective treatment options for lung cancer patients.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $1,559,462

Program Service Revenue $309,474

Investment Income $45,098

Other Revenue $0

TOTAL REVENUE $1,914,034

Expense Breakdown

Grants Paid $0

Salaries & Benefits $425,393

Fundraising Expenses $62,781

Program Expenses $1,349,312

Other Expenses $1,159,831

TOTAL EXPENSES $1,585,224

Year-over-Year Comparison

	2024	2023	Change
Revenue	$1,914,034	$1,553,569	+0.2%
Expenses	$1,585,224	$1,112,960	+0.4%
Net Income	$328,810	$440,609	-0.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Richard Erwin	Sr. Dir. Clinical Operations	40.00		$221,088	$9,783	$230,871
Tony Addario Chair	CEO	40.00	Officer Director	$0	$0	$0
Ken Krantz	CEO	40.00	Officer Director	$0	$0	$0
Bonnie Addario	Director	5.00	Director	$0	$0	$0
Bruce Gellman	Director	0.46	Director	$0	$0	$0
Gary Ingenito	Director	0.46	Director	$0	$0	$0
Steve Cavan Treasurer	Director	0.46	Director	$0	$0	$0
Tom Krohn RPh MBA	Director	0.46	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$1,914,034	$1,585,224	$2,244,730	$328,810
2023	$1,553,569	$1,112,960	$1,490,643	$440,609
2022	$1,061,978	$987,672	$1,003,534	$74,306
2021	$1,553,644	$1,086,366	$1,036,268	$467,278
2020	$919,609	$943,930	$578,817	$-24,321
2019	$987,238	$977,138	$472,232	$10,100
2018	$1,516,110	$1,192,998	$465,281	$323,112

Addario Lung Cancer Medical Institute